Murray H. Passo

National Institutes of Health — United States

Medicine · Health Sciences

53h-index8.0kcitations141works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Autoimmune and Inflammatory Disorders Research(78), Adolescent and Pediatric Healthcare(36), Systemic Lupus Erythematosus Research(20), Immunodeficiency and Autoimmune Disorders(20), Inflammatory Myopathies and Dermatomyositis(18)

Publications139 total

Evaluating Legacy and Emerging PFAS in Human Blood Collected from 2003 to 2021
Environmental Science & Technology·2026· 1 citedOpen Access
Diffuse Alveolar Hemorrhage – A Devastating Complication of Drug-induced Lupus
American Journal of Respiratory and Critical Care Medicine·2025· 1 cited
Association of anti-TPM4 autoantibodies with vasculopathic cutaneous manifestations in juvenile dermatomyositis
Lara D. Veeken·2023Open Access
Constitutively active Lyn kinase causes a cutaneous small vessel vasculitis and liver fibrosis syndrome
Nature Communications·2023· 27 citedOpen Access
Measuring Process of Arthritis Care. A Proposed Set of Quality Measures for the Process of Care in Juvenile Idiopathic Arthritis
UNC Libraries·2020Open Access
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis
Arthritis Care & Research·2019· 292 citedOpen Access
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis–Associated Uveitis
Arthritis & Rheumatology·2019· 103 citedOpen Access
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non‐Systemic Polyarthritis, Sacroiliitis, and Enthesitis
Arthritis Care & Research·2019· 450 citedOpen Access
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Non‐Systemic Polyarthritis, Sacroiliitis, and Enthesitis
Arthritis & Rheumatology·2019· 183 cited
Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti–Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy
Arthritis & Rheumatology·2018· 79 cited
Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti–Tumor Necrosis Factor Therapy in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis With Clinically Inactive Disease
Arthritis & Rheumatology·2018· 36 cited
High Levels of <scp>DEK</scp> Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti–Tumor Necrosis Factor Therapy
Arthritis & Rheumatology·2017· 16 citedOpen Access
Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America
Pediatric Rheumatology·2017· 51 citedOpen Access
Childhood-onset Systemic Lupus Erythematosus Complicated by Posterior Reversible Encephalopathy Syndrome in The Context of Kidney Dialysis and Plasma Exchange in Pediatric Lupus
Journal of Pediatric Neurology·2016· 1 cited
Methods for Developing the American College of Rheumatology's Electronic Clinical Quality Measures
Arthritis Care & Research·2016· 16 cited
Understanding the biology and use of TNF therapy in jia-clinical outcomes
Pediatric Rheumatology·2014Open Access
High levels of DEK autoantibodies may predict early flare following cessation of anti-TNF therapy in juvenile idiopathic arthritis
Pediatric Rheumatology·2014Open Access
Identifying treatment responders and predictors of improvement after cognitive-behavioral therapy for juvenile fibromyalgia
Pain·2014· 69 citedOpen Access
A20: Understanding the Use and Biology of TNF Therapy in JIA—Clinical Outcomes
Arthritis & Rheumatology·2014· 1 cited
A151: Pediatric Rheumatology Care and Outcomes Improvement Network Demonstrates Performance Improvement on Juvenile Idiopathic Arthritis Quality Measures
Arthritis & Rheumatology·2014· 4 cited
page 1 of 7Next →

Frequent Co-authors

Daniel J. Lovell(15), Hermine I. Brunner(12), T. Brent Graham(11), Alexei A. Grom(10), Edward H. Giannini(9), Kenneth N. Schikler(9), Brian M. Feldman(8), Lawrence Zemel(8), Robert M. Rennebohm(7), Susmita Kashikar‐Zuck(7), Tracy V. Ting(7), Timothy Beukelman(6), Carol B. Lindsley(6), Philip J. Hashkes(6), A. Lynch-Jordan(6), David N. Glass(6), Robert A. Colbert(5), Rayfel Schneider(5), S. Ballinger(5), Ann M. Reed(5)